skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Good morning, 5i Team,

Based on the answers and comments you make about NBIS I can deduce that you like NBIS yet confused about price action. That makes at least two of us.
Are you able to share your thinking process of what might be happening with this instrument. Is it simply favored by the speculative bunch?

I closed my position yesterday, but I find it hard to resist to re-enter today.

Thank you as always

Nick

Read Answer Asked by Nick on March 18, 2026
Q: Hi, given recent action, including a nice jump by Nebius, but keeping in mind possible cyclicity, can you please rank these five stocks as possible best buys today, indicate whether they are buy, hold or sell, and give a small blurb why they are worth buying today. 3-4 year holding. Thank you
Read Answer Asked by GeeMac on March 18, 2026
Q: Hi, Your thoughts for 4 stocks: RGTI Rigetti Computing,
QBTS D-Wave Quantum, QUBT Quantum Computing Inc.
IONQ IonQ,Inc.
Thanks Have a nice day. Jean Guy
Read Answer Asked by Jean Guy on March 18, 2026
Q: I own MU and SNDK, totalling 4% of my holdings. Would adding KLAC, LRCX, or AMAT be too much in semis? Or would u just increase my MU or SNDK holdings?
Read Answer Asked by Graeme on March 18, 2026
Q: Could have I an update on your views on Medtronic’s and Qualcomm. Its hold in a RRSP. Would you suggest 1-2 companies for each one with better or same risk profile you would suggest to switch for if you think that’s a good idea .
Read Answer Asked by Olivier on March 17, 2026
Q: Hi,

Already holding HPS.A at 3.6% and I like the growing power thesis. Do you think buying ENS, MPWR or APH would be too much? I like the growth of all these other names but is owning all four too many? How would you rank them to buy now for best risk adjusted return?
Read Answer Asked by Keith on March 17, 2026
Q: between the 2 credit card companies, which is presently the better buy. my metric is present dividend yield compared to
5yr low, 5yr high, 5yr median and
10yr low, 10yr high and 10yr median.
Please provide me those numbers.
Do you have an opinion about a different or more insightful metric to consider?
Read Answer Asked by Ernest on March 17, 2026
Q: For investors already active in US names, would you endorse continuing to hold GLXY into and after the TSX de-listing? Or, for example, do you feel there are more compelling names in the US crypto space to consider for a portfolio?
Read Answer Asked by Andrew on March 17, 2026
Q: Could you give me an update on your view on Starbucks since your last comments 8 months ago. I m holding it in an RRSP account and I am reviewing for maybe a better large cap consumer discretionary stock is you can suggest 2-3 .
Read Answer Asked by Olivier on March 16, 2026
Q: Has been getting a lot of positive news and contract wins. Thoughts on the META deal?

Seems the market is looking at the company as just an AI infrastructure play but they have many other lines of business that is not being taken into account.

I own both names and based on the momentum of NBIS does it make sense to sell IREN and consolidate? This will not impact position size materially of NBIS. Just seems like NBIS is more of a better quality business overall.
Read Answer Asked by Sal on March 16, 2026
Q: Can you comment on the new Nebius / Meta deal please? Is this one of the further contracts that were expected after the Microsoft deal in September? Does it change your outlook for the company? Or is it more of a confirmation. Thanks.
Read Answer Asked by Martin on March 16, 2026
Q: Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots.

Who really knows, what's your opinion on that.

If something like that did happen, which companys would you be investing in now?

Or is it early?

Thank you.
Read Answer Asked by Ross on March 16, 2026
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!